Logo image of ALNXT.PA

NEXTEDIA (ALNXT.PA) Stock Fundamental Analysis

Europe - EPA:ALNXT - FR0004171346 - Common Stock

0.435 EUR
0 (0%)
Last: 10/20/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ALNXT. ALNXT was compared to 73 industry peers in the IT Services industry. ALNXT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALNXT has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination!


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ALNXT had positive earnings in the past year.
ALNXT had a positive operating cash flow in the past year.
ALNXT had positive earnings in each of the past 5 years.
Of the past 5 years ALNXT 4 years had a positive operating cash flow.
ALNXT.PA Yearly Net Income VS EBIT VS OCF VS FCFALNXT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

With a Return On Assets value of 2.48%, ALNXT is not doing good in the industry: 61.64% of the companies in the same industry are doing better.
ALNXT has a worse Return On Equity (4.95%) than 61.64% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.08%, ALNXT is doing worse than 64.38% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ALNXT is significantly below the industry average of 20.36%.
Industry RankSector Rank
ROA 2.48%
ROE 4.95%
ROIC 6.08%
ROA(3y)2.64%
ROA(5y)3.08%
ROE(3y)5.31%
ROE(5y)6.42%
ROIC(3y)6.2%
ROIC(5y)6.1%
ALNXT.PA Yearly ROA, ROE, ROICALNXT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

ALNXT has a Profit Margin of 2.35%. This is in the lower half of the industry: ALNXT underperforms 60.27% of its industry peers.
ALNXT's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 4.77%, ALNXT perfoms like the industry average, outperforming 42.47% of the companies in the same industry.
ALNXT's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 55.35%, ALNXT is in line with its industry, outperforming 42.47% of the companies in the same industry.
ALNXT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.77%
PM (TTM) 2.35%
GM 55.35%
OM growth 3Y-10.16%
OM growth 5Y-2.26%
PM growth 3Y-8.02%
PM growth 5Y-2.63%
GM growth 3Y-8.46%
GM growth 5Y-11.02%
ALNXT.PA Yearly Profit, Operating, Gross MarginsALNXT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALNXT is destroying value.
Compared to 1 year ago, ALNXT has about the same amount of shares outstanding.
ALNXT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALNXT has an improved debt to assets ratio.
ALNXT.PA Yearly Shares OutstandingALNXT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ALNXT.PA Yearly Total Debt VS Total AssetsALNXT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

ALNXT has an Altman-Z score of 1.89. This is not the best score and indicates that ALNXT is in the grey zone with still only limited risk for bankruptcy at the moment.
ALNXT has a Altman-Z score of 1.89. This is in the lower half of the industry: ALNXT underperforms 64.38% of its industry peers.
ALNXT has a debt to FCF ratio of 2.63. This is a good value and a sign of high solvency as ALNXT would need 2.63 years to pay back of all of its debts.
ALNXT has a better Debt to FCF ratio (2.63) than 68.49% of its industry peers.
ALNXT has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
ALNXT's Debt to Equity ratio of 0.15 is amongst the best of the industry. ALNXT outperforms 82.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 2.63
Altman-Z 1.89
ROIC/WACC0.9
WACC6.73%
ALNXT.PA Yearly LT Debt VS Equity VS FCFALNXT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

ALNXT has a Current Ratio of 1.18. This is a normal value and indicates that ALNXT is financially healthy and should not expect problems in meeting its short term obligations.
ALNXT has a Current ratio of 1.18. This is comparable to the rest of the industry: ALNXT outperforms 50.68% of its industry peers.
ALNXT has a Quick Ratio of 1.18. This is a normal value and indicates that ALNXT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.18, ALNXT is in line with its industry, outperforming 56.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.18
ALNXT.PA Yearly Current Assets VS Current LiabilitesALNXT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 216.26% over the past year.
Measured over the past 5 years, ALNXT shows a small growth in Earnings Per Share. The EPS has been growing by 3.66% on average per year.
Looking at the last year, ALNXT shows a small growth in Revenue. The Revenue has grown by 6.76% in the last year.
The Revenue has been growing by 21.48% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)216.26%
EPS 3Y-3.66%
EPS 5Y3.66%
EPS Q2Q%90.52%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y8.74%
Revenue growth 5Y21.48%
Sales Q2Q%3.58%

3.2 Future

Based on estimates for the next years, ALNXT will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.47% on average per year.
The Revenue is expected to grow by 8.18% on average over the next years. This is quite good.
EPS Next Y20.64%
EPS Next 2Y9.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.87%
Revenue Next 2Y8.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALNXT.PA Yearly Revenue VS EstimatesALNXT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALNXT.PA Yearly EPS VS EstimatesALNXT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2022 2023 2024 2025 2026 0.02 0.04 0.06 0.08

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.88, which indicates a very decent valuation of ALNXT.
ALNXT's Price/Earnings ratio is rather cheap when compared to the industry. ALNXT is cheaper than 89.04% of the companies in the same industry.
When comparing the Price/Earnings ratio of ALNXT to the average of the S&P500 Index (27.69), we can say ALNXT is valued rather cheaply.
The Price/Forward Earnings ratio is 4.66, which indicates a rather cheap valuation of ALNXT.
93.15% of the companies in the same industry are more expensive than ALNXT, based on the Price/Forward Earnings ratio.
ALNXT is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.18, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.88
Fwd PE 4.66
ALNXT.PA Price Earnings VS Forward Price EarningsALNXT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ALNXT is valued cheaply inside the industry as 86.30% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.7
EV/EBITDA N/A
ALNXT.PA Per share dataALNXT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

ALNXT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.53
PEG (5Y)2.97
EPS Next 2Y9.47%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALNXT!.
Industry RankSector Rank
Dividend Yield N/A

NEXTEDIA

EPA:ALNXT (10/20/2025, 7:00:00 PM)

0.435

0 (0%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners17.68%
Ins Owner ChangeN/A
Market Cap16.97M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 10.88
Fwd PE 4.66
P/S 0.26
P/FCF 6.7
P/OCF 6.52
P/B 0.55
P/tB 39.28
EV/EBITDA N/A
EPS(TTM)0.04
EY9.2%
EPS(NY)0.09
Fwd EY21.45%
FCF(TTM)0.06
FCFY14.93%
OCF(TTM)0.07
OCFY15.35%
SpS1.66
BVpS0.79
TBVpS0.01
PEG (NY)0.53
PEG (5Y)2.97
Profitability
Industry RankSector Rank
ROA 2.48%
ROE 4.95%
ROCE 8.55%
ROIC 6.08%
ROICexc 8.32%
ROICexgc N/A
OM 4.77%
PM (TTM) 2.35%
GM 55.35%
FCFM 3.92%
ROA(3y)2.64%
ROA(5y)3.08%
ROE(3y)5.31%
ROE(5y)6.42%
ROIC(3y)6.2%
ROIC(5y)6.1%
ROICexc(3y)8.02%
ROICexc(5y)8.4%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.71%
ROCE(5y)8.58%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-9.69%
ROICexc growth 5Y-0.48%
OM growth 3Y-10.16%
OM growth 5Y-2.26%
PM growth 3Y-8.02%
PM growth 5Y-2.63%
GM growth 3Y-8.46%
GM growth 5Y-11.02%
F-Score7
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 2.63
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.11%
Interest Coverage 250
Cash Conversion N/A
Profit Quality 166.85%
Current Ratio 1.18
Quick Ratio 1.18
Altman-Z 1.89
F-Score7
WACC6.73%
ROIC/WACC0.9
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.47%
Cap/Sales(5y)0.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)216.26%
EPS 3Y-3.66%
EPS 5Y3.66%
EPS Q2Q%90.52%
EPS Next Y20.64%
EPS Next 2Y9.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.76%
Revenue growth 3Y8.74%
Revenue growth 5Y21.48%
Sales Q2Q%3.58%
Revenue Next Year13.87%
Revenue Next 2Y8.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.78%
EBIT growth 3Y-2.31%
EBIT growth 5Y18.73%
EBIT Next Year22.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y104.05%
FCF growth 3Y-11.08%
FCF growth 5YN/A
OCF growth 1Y79.43%
OCF growth 3Y-10.82%
OCF growth 5YN/A